Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention

The Prostate Cancer Prevention Trial (PCPT) showed a risk of prostate cancer at prostate-specific antigen (PSA)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer prevention research (Philadelphia, Pa.) Pa.), 2008-08, Vol.1 (3), p.167-173
Hauptverfasser:	Lucia, M Scott, Darke, Amy K, Goodman, Phyllis J, La Rosa, Francisco G, Parnes, Howard L, Ford, Leslie G, Coltman, Jr, Charles A, Thompson, Ian M
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents - therapeutic use Biopsy Chemoprevention - methods Early Detection of Cancer Finasteride - therapeutic use Follow-Up Studies Humans Lymphatic Metastasis Male Middle Aged Neoplasm Invasiveness Organ Size Placebos Prostate-Specific Antigen - analysis Prostatic Neoplasms - diagnosis Prostatic Neoplasms - etiology Prostatic Neoplasms - pathology Prostatic Neoplasms - prevention & control Risk Factors Treatment Outcome Tumor Burden
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The Prostate Cancer Prevention Trial (PCPT) showed a risk of prostate cancer at prostate-specific antigen (PSA)
ISSN:	1940-6207 1940-6215
DOI:	10.1158/1940-6207.CAPR-08-0078